The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of systemic delays in targeted therapy (TT) access for advanced NSCLC (aNCSLC) with actionable genomic alterations (AGA+) in Alberta, Canada.
 
Vishal Navani
Honoraria - AstraZeneca; Bristol-Myers Squibb/Medarex; EMD Serono; Ipsen; Janssen; Pfizer; Sanofi Pasteur
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Novotech; Pfizer
Speakers' Bureau - Ekas; Ipsos; Kyowa Kirin
Research Funding - Bioscript
Travel, Accommodations, Expenses - Boehringer Ingelheim; EMD Serono; Pfizer; Sanofi; Sanofi
 
Amanda Gibson
No Relationships to Disclose
 
Michelle Dean
No Relationships to Disclose
 
Mobolaji Bosede
No Relationships to Disclose
 
Carla Pires Amaro
No Relationships to Disclose
 
Rodrigo Rigo
No Relationships to Disclose
 
Randeep Sangha
Honoraria - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; Lilly; Merck; Pfizer; Roche/Genentech; Sanofi; Takeda; Teva
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; Lilly; Merck; Novartis; Roche/Genentech; Sanofi; Takeda; Teva; Teva
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Merck Serono (Inst); MorphoSys (Inst); Novartis (Inst); Pharmacyclics (Inst); Roche (Inst); Takeda (Inst)
 
Doreen Ezeife
Honoraria - Bristol-Myers Squibb; Pfizer
Consulting or Advisory Role - AstraZeneca; Canada's Drug Agency; Novartis